High-density lipoprotein cholesterol (HDL-C) and alanine aminotransferase (ALT) were linked to the risk of NAFLD and T2DM, according to some recent research [12–14]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.